Article Cited by others


Androgen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysis

Lei Jun-Hao, Liu Liang-Ren, Wei Qiang, Song Tu-Run, Yang Lu, Meng Yang, Han Ping

Year : 2016| Volume: 18| Issue : 1 | Page no: 102-107

   This article has been cited by
1 Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment
Cem Onal,Fatih Kose,Gokhan Ozyigit,Sercan Aksoy,Ezgi Oymak,Sadik Muallaoglu,Ozan C. Guler,Burak Tilki,Pervin Hurmuz,Fadil Akyol
The Prostate. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway
Jing Chu,Yutong Li,Zhihai Deng,Zhenlin Zhang,Qun Xie,Heyuan Zhang,Weifeng Zhong,Bin Pan
BioMed Research International. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
3 Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence
Lorenzo Livi,Beatrice Detti,Giulio Francolini,Francesca Terziani,Luca Triggiani,Rolando M. D’Angelillo,Gianluca Ingrosso
Tumori Journal. 2019; 105(4): 277
[Pubmed]  [Google Scholar] [DOI]
4 IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer
Hao Ping,Feiya Yang,Mingshuai Wang,Yinong Niu,Nianzeng Xing
Oncology Reports. 2016; 36(3): 1658
[Pubmed]  [Google Scholar] [DOI]
5 Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway
Bin Pan,Weifeng Zhong,Zhihai Deng,Caiyong Lai,Jing Chu,Genlong Jiao,Junfeng Liu,Qizhao Zhou
Cancer Medicine. 2016; 5(11): 3214
[Pubmed]  [Google Scholar] [DOI]


Read this article